Subject: RXMD Announces Record Revenues and an 80% Increase in Prescriptions Filled

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
RXMD Announces Record Revenues and an 80% Increase in Prescriptions Filled
Hot Stock to WatchHot Stock to Watch

Company: Progressive Care Inc. (OTCQB: RXMD)


Price: 0.065

Change (%): + 0.009 (16.07)

Volume: 544,380
NGTF Chart

Progressive Care Inc. Doubles Revenue: Reports $3.3 Million for June 2019

MIAMI, July 17, 2019 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced record revenues of $3.3 Million for June 2019 and an 80% increase in prescriptions filled at nearly 46,000 total.

June 2019 represents the first month of consolidated revenue for Progressive Care, which includes 4 locations in Florida. The Company recorded a 100% increase in gross revenues at $3.3 million exclusive of PBM fees and nearly 46,000 prescriptions filled. Prescriptions filled have grown steadily for all locations, especially PharmCo Palm Beach which increased by 38% and yielded a 165% increase in revenues.

“This was the first month of having 4 locations under our umbrella,” said S. Parikh Mars, Chief Executive Officer of Progressive Care Inc. “We are more than pleased with the performance last month as it exceeded our expectations. Yet, we are focused on the potential for growth and are working on major big picture goals throughout the rest of the year.”

Continue Reading

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks